Resveratrol-induced autophagocytosis in ovarian cancer cells

Anthony W Opipari1, Lijun Tan, Anthony E Boitano

  • 1Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan 48109, USA. rliu@umich.edu

Cancer Research
|January 28, 2004
PubMed

Insights

Resveratrol induces cell death in ovarian cancer cells through a non-apoptotic pathway, offering a potential strategy for chemoresistant cancers. This natural compound may bypass typical apoptosis resistance mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Resveratrol, a natural phytoalexin found in grapes and red wine, exhibits antineoplastic properties.
  • Its molecular mechanisms of action against cancer cells are under investigation.
  • Ovarian cancer often develops resistance to conventional chemotherapy, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To investigate the effects of resveratrol on human ovarian carcinoma cell lines.
  • To elucidate the specific cell death pathways induced by resveratrol in these cells.
  • To explore resveratrol's potential as a therapeutic agent for chemoresistant ovarian cancer.

Main Methods:

  • Treatment of five human ovarian carcinoma cell lines with resveratrol.
  • Analysis of cell death markers, including cytochrome c release, apoptosome formation, and caspase activation.
  • Morphological and ultrastructural examination using light and electron microscopy.
  • Assessment of resveratrol sensitivity in cells expressing antiapoptotic proteins Bcl-x(L) and Bcl-2.

Main Results:

  • Resveratrol inhibited growth and induced cell death in ovarian cancer cell lines.
  • While some markers of apoptosis were observed, microscopy revealed features of autophagic cell death.
  • Resveratrol-treated cells exhibited ultrastructural changes indicative of autophagocytic processes.
  • Cells overexpressing antiapoptotic proteins Bcl-x(L) and Bcl-2 remained sensitive to resveratrol.

Conclusions:

  • Resveratrol induces cell death in ovarian cancer cells via a mechanism distinct from classical apoptosis, potentially involving autophagy.
  • This non-apoptotic cell death pathway suggests resveratrol may be effective against ovarian cancers resistant to apoptosis-based therapies.
  • Resveratrol represents a promising therapeutic candidate for overcoming chemoresistance in ovarian cancer.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...